A dynamic multi-organ-chip for long-term cultivation and substance testing proven by 3D human liver and skin tissue co-culture
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Current in vitro and animal tests for drug development are failing to emulate the systemic organ complexity of the human body and, therefore, to accurately predict drug toxicity. In this study, we present a multi-organ-chip capable of maintaining 3D tissues derived from cell lines, primary cells and biopsies of various human organs. We designed a multi-organ-chip with co-cultures of human artificial liver microtissues and skin biopsies, each a (1)/100,000 of the biomass of their original human organ counterparts, and have successfully proven its long-term performance. The system supports two different culture modes: i) tissue exposed to the fluid flow, or ii) tissue shielded from the underlying fluid flow by standard Transwell® cultures. Crosstalk between the two tissues was observed in 14-day co-cultures exposed to fluid flow. Applying the same culture mode, liver microtissues showed sensitivity at different molecular levels to the toxic substance troglitazone during a 6-day exposure. Finally, an astonishingly stable long-term performance of the Transwell®-based co-cultures could be observed over a 28-day period. This mode facilitates exposure of skin at the air-liquid interface. Thus, we provide here a potential new tool for systemic substance testing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“More recently, developers are increasingly starting to produce their chips from thermoplastic materials, already used in other biotechnological applications: polystyrene (Lee et al., 2018), poly(methyl methacrylate) (Busek et al., 2021), polycarbonate (Wagner et al., 2013), and cyclic olefin copolymer. While being amenable for cheaper and more scalable fabrication processes as well as providing”
From Recommendations on fit-for-purpose criteria to establish quality management for microphysiological systems and for monitoring their reproducibility (2024) · cites this paper as Wagner et al., 2013
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The metabolic activity and function of cells fluctuate over time and similar observations have been reported in the literature [61,62].”
From A liver-on-a-chip platform with bioprinted hepatic spheroids (2016) · cites this paper as [62]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
All About Albumin: Biochemistry, Genetics, and Medical Applications
Peters, T. (1995) · Thammasat University Digital Collections · Cited by 3,372
Capturing complex 3D tissue physiology in vitro
Griffith, L. G., & Swartz, M. A. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1858 · Cited by 2,290
From 3D cell culture to organs-on-chips
Huh, D., Hamilton, G. A., & Ingber, D. E. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.09.005 · Cited by 1,834
Infection of a human hepatoma cell line by hepatitis B virus
Gripon, P., Rumin, S., Urban, S., Le Seyec, J., Glaise, D., Cannie, I., Guyomard, C., Lucas, J., Trepo, C., & Guguen-Guillouzo, C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232137699 · Cited by 1,282
Perfused multiwell plate for 3D liver tissue engineering
Domansky, K., Inman, W., Serdy, J., Dash, A., Lim, M. H. M., & Griffith, L. G. (2010) · Lab Chip · doi:10.1039/b913221j · Cited by 444
Zhang, C., Zhao, Z., Abdul Rahim, N. A., van Noort, D., & Yu, H. (2009) · Lab on a Chip · doi:10.1039/b915147h · Cited by 340
Sung, J. H., Esch, M. B., Prot, J.-M., Long, C. J., Smith, A., Hickman, J. J., & Shuler, M. L. (2013) · Lab on a Chip · doi:10.1039/c3lc41017j · Cited by 233
Lübberstedt, M., Müller-Vieira, U., Mayer, M., Biemel, K. M., Knöspel, F., Knobeloch, D., Nüssler, A. K., Gerlach, J. C., & Zeilinger, K. (2011) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2010.04.013 · Cited by 227
Marx, U., Walles, H., Hoffmann, S., Lindner, G., Horland, R., Sonntag, F., Klotzbach, U., Sakharov, D., Tonevitsky, A., & Lauster, R. (2012) · Alternatives to Laboratory Animals · doi:10.1177/026119291204000504 · Cited by 177
Self-citationImura, Y., Sato, K., & Yoshimura, E. (2010) · Analytical Chemistry · doi:10.1021/ac100806x · Cited by 172
Research works printed but not linked: 1
- Ramachandran, 1999, Drug Metab. Dispos., 27, 1194
Cited by
Items 101–200 of 476
Autologous Induced Pluripotent Stem Cell-Derived Four-Organ-Chip
Ramme, A. P., Koenig, L., Hasenberg, T., Schwenk, C., Magauer, C., Faust, D., Lorenz, A. K., Krebs, A.-C., Drewell, C., Schirrmann, K., et al. (2019) · Future Science OA · doi:10.2144/fsoa-2019-0065 · Cited by 112
“Long-term stability and adjustability to various flow rates had been validated previously [13 , 14 , 18] .”
Self-citationAn Overview of Organs-on-Chips Based on Deep Learning
Li, J., Chen, J., Bai, H., Wang, H., Hao, S., Ding, Y., Peng, B., Zhang, J., Li, L., & Huang, W. (2022) · Research · doi:10.34133/2022/9869518 · Cited by 134
“In addition, interspecies di ff er-ences are an insurmountable gap between animal models and humans; thus, the experimental results for some disease models [11] and drug e ffi cacy studies [12] have deviated from those of humans.”
Resultde Barros, N. R., Kim, H., Gouidie, M. J., Lee, K., Bandaru, P., Banton, E. A., Sarikhani, E., Sun, W., Zhang, S., Cho, H., et al. (2020) · Biofabrication · doi:10.1088/1758-5090/aba503 · Cited by 112
Multiphase microfluidic synthesis of micro- and nanostructures for pharmaceutical applications
Ran, R., Sun, Q., Baby, T., Wibowo, D., Middelberg, A. P. J., & Zhao, C.-X. (2017) · Chemical Engineering Science · doi:10.1016/j.ces.2017.01.008 · Cited by 105
Coppeta, J. R., Mescher, M. J., Isenberg, B. C., Spencer, A. J., Kim, E. S., Lever, A. R., Mulhern, T. J., Prantil-Baun, R., Comolli, J. C., & Borenstein, J. T. (2017) · Lab on a Chip · doi:10.1039/c6lc01236a · Cited by 101
Design and Evaluation of an Osteogenesis-on-a-Chip Microfluidic Device Incorporating 3D Cell Culture
Bahmaee, H., Owen, R., Boyle, L., Perrault, C. M., Garcia-Granada, A. A., Reilly, G. C., & Claeyssens, F. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.557111 · Cited by 100
A review of peristaltic micropumps
Forouzandeh, F., Arevalo, A., Alfadhel, A., & Borkholder, D. A. (2021) · Sensors and Actuators A Physical · doi:10.1016/j.sna.2021.112602 · Cited by 101
Jiang, K., Chaimov, D., Patel, S. N., Liang, J.-P., Wiggins, S. C., Samojlik, M. M., Rubiano, A., Simmons, C. S., & Stabler, C. L. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.08.057 · Cited by 98
“Multiple MPS platforms mimicking the heart, lung, liver, and vasculature have been developed [1-4].”
Zhang, Y., Ge, S., & Yu, J. (2016) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2016.09.008 · Cited by 107
The Multi-organ Chip - A Microfluidic Platform for Long-term Multi-tissue Coculture
Materne, E.-M., Maschmeyer, I., Lorenz, A. K., Horland, R., Schimek, K. M. S., Busek, M., Sonntag, F., Lauster, R., & Marx, U. (2015) · Journal of Visualized Experiments · doi:10.3791/52526 · Cited by 95
Self-citationOrgans-on-chip monitoring: sensors and other strategies
Kilic, T., Navaee, F., Stradolini, F., Renaud, P., & Carrara, S. (2018) · Microphysiological Systems · doi:10.21037/mps.2018.01.01 · Cited by 96
“And followed by more complicated platforms that connects two or more organs (7-9).”
BackgroundOn-chip three-dimensional cell culture in phaseguides improves hepatocyte functions in vitro
Jang, M., Neuzil, P., Volk, T., Manz, A., & Kleber, A. (2015) · Biomicrofluidics · doi:10.1063/1.4922863 · Cited by 95
Microfluidic-based vascularized microphysiological systems
Lee, S., Ko, J., Park, D., Lee, S.-R., Chung, M., Lee, Y., & Jeon, N. L. (2018) · Lab on a Chip · doi:10.1039/c8lc00285a · Cited by 91
Translational Roadmap for the Organs-on-a-Chip Industry toward Broad Adoption
Allwardt, V., Ainscough, A. J., Viswanathan, P., Sherrod, S. D., McLean, J. A., Haddrick, M., & Pensabene, V. (2020) · Bioengineering · doi:10.3390/bioengineering7030112 · Cited by 88
“Many groups have developed multi-organ-on-a-chip systems, including liver-skin [28], intestine-kidney [29], and skin-hair models [30].”
BackgroundWilk–Zasadna, I., Bernasconi, C., Pelkonen, O., & Coecke, S. (2014) · Toxicology · doi:10.1016/j.tox.2014.10.006 · Cited by 102
“, 3D in improved matrix environment, shows promising results for prolonging the metabolic competence of the chosen test system (Darnell et al., 2011; Godoy et al., 2013; Leite et al., 2012; Lübberstedt et al., 2012; Mandenius et al., 2011; Miranda et al., 2009; Tostões et al., 2012; Wagner et al., 2013; Zeilinger et a…”
BackgroundEngineered Liver Platforms for Different Phases of Drug Development
Ware, B. R., & Khetani, S. R. (2017) · Trends in Biotechnology · doi:10.1016/j.tibtech.2016.08.001 · Cited by 90
“Other groups have used biochips to study liver-skin interactions in troglitazone-induced toxicity [70] and topical substance exposure [71].”
BackgroundNagahama, K., Kimura, Y., & Takemoto, A. (2018) · Nature Communications · doi:10.1038/s41467-018-04699-3 · Cited by 101
Zheng, F., Xiao, Y., Liu, H., Fan, Y., & Dao, M. (2021) · Advanced Biology · doi:10.1002/adbi.202000024 · Cited by 107
Controlling Differentiation of Stem Cells for Developing Personalized Organ‐on‐Chip Platforms
Geraili, A., Jafari, P., Hassani, M. S., Araghi, B. H., Mohammadi, M. H., Ghafari, A. M., Tamrin, S. H., Modarres, H. P., Kolahchi, A. R., Ahadian, S., et al. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201700426 · Cited by 88
The application of 3D cell models to support drug safety assessment: Opportunities & challenges
Roth, A. B., & Singer, T. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.12.005 · Cited by 105
“Today, models are available not only to address effects induced by topical application of cosmetics, for example, but also skin changes arising from topical as well as systemic application of drugs to healthy [86,87] as well as diseased tissue [88].”
Microphysiological Systems: Design, Fabrication, and Applications
Wang, K., Man, K., Liu, J., Liu, Y., Chen, Q., Zhou, Y., & Yang, Y. S. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01667 · Cited by 90
Alexander, F. A., Eggert, S., & Wiest, J. (2018) · Genes · doi:10.3390/genes9020114 · Cited by 82
Recent advances in microfluidic technologies for organ-on-a-chip
Tian, C., Tu, Q., Liu, W., & Wang, J. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2019.06.005 · Cited by 90
Organ-on-a-chip for assessing environmental toxicants
Cho, S., & Yoon, J. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2016.11.019 · Cited by 87
Integration Concepts for Multi-Organ Chips: How to Maintain Flexibility?!
Rogal, J., Probst, C., & Loskill, P. (2017) · Future Science OA · doi:10.4155/fsoa-2016-0092 · Cited by 86
Watson, D. E., Hunziker, R., & Wikswo, J. P. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217732765 · Cited by 78
Advances in static in vitro digestion models after the COST action Infogest consensus protocol
Colombo, R., Ferron, L., Frosi, I., & Papetti, A. (2021) · Food & Function · doi:10.1039/d1fo01089a · Cited by 93
Applications, materials, and fabrication of micro glass parts and devices: An overview
Hamed, H., Eldiasty, M., Seyedi-Sahebari, S.-M., & Ziki, J. D. A. (2023) · Materials Today · doi:10.1016/j.mattod.2023.03.005 · Cited by 81
Hübner, J., Raschke, M., Rütschle, I., Gräßle, S., Hasenberg, T., Schirrmann, K., Lorenz, A., Schnurre, S., Lauster, R., Maschmeyer, I., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-33462-3 · Cited by 75
Self-citationModarres, H. P., Janmaleki, M., Novin, M., Saliba, J., Moussa, F. E. H., Charan, M. R., Seyfoori, A., SadAbadi, H., Vandal, M., Nguyen, M. D., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.01.024 · Cited by 80
“[305], d) The microfluidic four-organ-chip accommodating a surrogate blood flow circuit and an excretory flow circuit.”
BackgroundNanotheranostics Targeting the Tumor Microenvironment
Roma‐Rodrigues, C., Pombo, I., Raposo, L. R., Pedrosa, P., Fernandes, A. R., & Baptista, P. V. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00197 · Cited by 84
“The combination of different cell types, from liver and skin, within a multi-organ-chip, proved their potential in therapeutic drug testing (Wagner et al., 2013).”
BackgroundRoadblocks confronting widespread dissemination and deployment of Organs on Chips
Alver, C. G., Drabbe, E., Ishahak, M., & Agarwal, A. (2024) · Nature Communications · doi:10.1038/s41467-024-48864-3 · Cited by 74
Skin Diseases Modeling using Combined Tissue Engineering and Microfluidic Technologies
Mohammadi, M. H., Heidary Araghi, B., Beydaghi, V., Geraili, A., Moradi, F., Jafari, P., Janmaleki, M., Valente, K. P., Akbari, M., & Sanati‐Nezhad, A. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600439 · Cited by 74
AC Electrothermal Circulatory Pumping Chip for Cell Culture
Lang, Q., Wu, Y., Ren, Y., Tao, Y., Lei, L., & Jiang, H. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b08863 · Cited by 77
Multi-chamber microfluidic platform for high-precision skin permeation testing
Alberti, M., Dancik, Y., Sriram, G., Wu, B., Teo, Y. L., Feng, Z., Bigliardi‐Qi, M., Wu, R., Wang, Z. P., & Bigliardi, P. L. (2017) · Lab on a Chip · doi:10.1039/c6lc01574c · Cited by 81
Kim, J.-Y., Fluri, D. A., Kelm, J. M., Hierlemann, A., & Frey, O. (2015) · SLAS Technology · doi:10.1177/2211068214564056 · Cited by 72
Kim, J. J., Ellett, F., Thomas, C. N., Jalali, F., Anderson, R. R., Irimia, D., & Raff, A. B. (2019) · Lab on a Chip · doi:10.1039/c9lc00399a · Cited by 69
3D printed conformal microfluidics for isolation and profiling of biomarkers from whole organs
Singh, M., Tong, Y., Webster, K., Cesewski, E., Haring, A. P., Laheri, S., Carswell, B., O’Brien, T. J., Aardema, C. H., Senger, R. S., et al. (2017) · Lab on a Chip · doi:10.1039/c7lc00468k · Cited by 75
Microfluidic Organ-on-a-Chip Devices for Liver Disease Modeling In Vitro
Kanabekova, P., Kadyrova, A., & Kulsharova, G. (2022) · Micromachines · doi:10.3390/mi13030428 · Cited by 70
“However, metabolic activity and function of cells including the production of albumin are reported to vary over time [94,95].”
BackgroundDesign of hydrogel-based scaffolds for in vitro three-dimensional human skin model reconstruction
Tan, S. H., Chua, D. A. C., Tang, J. R. J., Bonnard, C., Leavesley, D. I., & Liang, K. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.09.068 · Cited by 77
The Ascendance of Microphysiological Systems to Solve the Drug Testing Dilemma
Dehne, E.-M., Hasenberg, T., & Marx, U. (2017) · Future Science OA · doi:10.4155/fsoa-2017-0002 · Cited by 68
Self-citationPreclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction
Segovia-Zafra, A., Di Zeo-Sánchez, D. E., López-Gómez, C., Pérez-Valdés, Z., García-Fuentes, E., Andrade, R. J., Lucena, M. I., & Villanueva-Paz, M. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.11.013 · Cited by 70
“Moreover, Wagner et al.(54) designed a MOC with co-cultures of human artificial liver microtissues and skin biopsies, to study livereskin interactions.”
BackgroundPowering ex vivo tissue models in microfluidic systems
McLean, I. C., Schwerdtfeger, L., Tobet, S. A., & Henry, C. S. (2018) · Lab on a Chip · doi:10.1039/c8lc00241j · Cited by 76
Shroff, T., Aina, K., Maass, C., Cipriano, M., Lambrecht, J., Tacke, F., Mosig, A., & Loskill, P. (2022) · Open Biology · doi:10.1098/rsob.210333 · Cited by 68
“[94], human liver microtissues and skin biopsies were studied for drug metabolism and inter-tissue cross-talk for up to 14 days of co-culture with trogalitazone [94].”
BackgroundAlternative in vitro models used in the main safety tests of cosmetic products and new challenges
Filaire, E., Nachat, R., Camille, L., Harmand, M., Simon, M., & Poinsot, C. (2022) · International Journal of Cosmetic Science · doi:10.1111/ics.12803 · Cited by 67
“Other investigations, using this transferred skin chip approach, developed a microfluidic chip for coculturing skin and liver [43], designed a multiorgan chip including skin and hair [44] or created a fourorgan system including the skin, liver, kidney and intestine [45].”
MethodPamies, D., Ekert, J., Zurich, M.-G., Frey, O., Werner, S., Piergiovanni, M., Freedman, B. S., Keong Teo, A. K., Erfurth, H., Reyes, D. R., et al. (2024) · Stem Cell Reports · doi:10.1016/j.stemcr.2024.03.009 · Cited by 88
Sung, J. H., Wang, Y., & Shuler, M. L. (2019) · APL Bioengineering · doi:10.1063/1.5097675 · Cited by 66
In vitro skin three-dimensional models and their applications
Klicks, J., von Molitor, E., Ertongur-Fauth, T., Rudolf, R., & Hafner, M. (2017) · Journal of Cellular Biotechnology · doi:10.3233/jcb-179004 · Cited by 66
Skin-on-a-Chip Technology: Microengineering Physiologically Relevant In Vitro Skin Models
Zoio, P., & Oliva, A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030682 · Cited by 76
Targeting the Complexity of In Vitro Skin Models: A Review of Cutting-Edge Developments
Quílez, C., Bebiano, L. B., Jones, E., Maver, U., Meesters, L., Parzymies, P., Petiot, E., Rikken, G., Risueño, I., Zaidi, H., et al. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.04.032 · Cited by 65
Engineering Liver Microtissues for Disease Modeling and Regenerative Medicine
Huang, D. (., Gibeley, S. B., Xu, C., Xiao, Y., Celik, O., Ginsberg, H. N., & Leong, K. W. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909553 · Cited by 65
Ashammakhi, N. A., Darabi, M. A., Çelebi‐Saltik, B., Tutar, R., Hartel, M. C., Lee, J., Hussein, S. M., Goudie, M. J., Cornelius, M. B., Dokmeci, M. R., et al. (2019) · Small Methods · doi:10.1002/smtd.201900589 · Cited by 74
Advances in Engineered Liver Models for Investigating Drug-Induced Liver Injury
Lin, C., & Khetani, S. R. (2016) · BioMed Research International · doi:10.1155/2016/1829148 · Cited by 66
A Minimized Valveless Electromagnetic Micropump for Microfluidic Actuation on Organ Chips
Mi, S., Pu, H., Xia, S., & Sun, W. (2020) · Sensors and Actuators A: Physical · doi:10.1016/j.sna.2019.111704 · Cited by 64
Current advances in skin-on-a-chip models for drug testing
Zhang, Q., Sito, L., Mao, M., He, J., Zhang, Y. S., & Zhao, X. (2018) · Microphysiological Systems · doi:10.21037/mps.2018.08.01 · Cited by 63
“, a multi-organ microfluidic device was established to integrate human skin biopsies and human primary hepatocytes (46).”
BackgroundOrgan-on-a-Chip Applications in Microfluidic Platforms
An, L., Liu, Y., & Liu, Y. (2025) · Micromachines · doi:10.3390/mi16020201 · Cited by 79
Human immunity in vitro — Solving immunogenicity and more
Giese, C., & Marx, U. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.12.011 · Cited by 67
“011 E D P R O O F exposure over seven days are possible [204].”
BackgroundInfluentialSelf-citationOptimizing drug discovery by Investigative Toxicology: Current and future trends
Beilmann, M., Boonen, H., Czich, A., Dear, G., Hewitt, P., Mow, T., Newham, P., Oinonen, T., Pognan, F., Roth, A., et al. (2018) · ALTEX · doi:10.14573/altex.1808181 · Cited by 85
Temporal Monitoring of Differentiated Human Airway Epithelial Cells Using Microfluidics
Blume, C., Reale, R., Held, M., Millar, T. M., Collins, J. E., Davies, D. E., Morgan, H., & Swindle, E. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139872 · Cited by 64
Modeling Immunity In Vitro: Slices, Chips, and Engineered Tissues
Hammel, J. H., Cook, S. R., Belanger, M. C., Munson, J. M., & Pompano, R. R. (2021) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-082420-124920 · Cited by 63
“In a study by Sieber et al. (30), a multiorgan chip (MOC) developed previously (31) was used to culture human HSPCs in a ceramic scaffold.”
Lin, N., Zhou, X., Geng, X., Drewell, C., Hübner, J., Zuo-gang, L., Zhang, Y., Xue, M., Marx, U., & Li, B. (2020) · Scientific Reports · doi:10.1038/s41598-020-65817-0 · Cited by 63
Self-citationKoning, J. J., Neves, C. T. R., Schimek, K. M. S., Thon, M., Spiekstra, S. W., Waaijman, T., de Gruijl, T. D., & Gibbs, S. (2022) · Frontiers in Toxicology · doi:10.3389/ftox.2021.824825 · Cited by 64
“…skin or lung models with human liver spheroids (Maschmeyer et al., 2015a; Schimek et al., 2020), and 4-OoCmodels include a preformed skin and human intestine being co-cultured with liver spheroids and human proximal tubule epithelial cells (kidney) (Wagner et al., 2013; Maschmeyer et al., 2015b).”
BackgroundGröger, M., Rennert, K., Giszas, B., Weiß, E., Dinger, J., Funke, H., Kiehntopf, M., Peters, F. T., Lupp, A., Bauer, M., et al. (2016) · Scientific Reports · doi:10.1038/srep21868 · Cited by 60
Microfluidic platforms for modeling biological barriers in the circulatory system
Yu, F., Kumar, N. D. O. S., Choudhury, D., Foo, L. C., & Ng, S. H. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.036 · Cited by 61
Recent advances and future applications of microfluidic live-cell microarrays
Rothbauer, M., Wartmann, D., Charwat, V., & Ertl, P. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.06.006 · Cited by 68
“8 (Wagner et al., 2013).”
MethodSelf-contained, low-cost Body-on-a-Chip systems for drug development
Wang, Y. I., Oleaga, C., Long, C. J., Esch, M. B., McAleer, C. W., Miller, P. G., Hickman, J. J., & Shuler, M. L. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217694101 · Cited by 59
A perfusable vascularized full-thickness skin model for potential topical and systemic applications
Salameh, S., Tissot, N., Cache, K., Lima, J., Suzuki, I., Marinho, P. A., Rielland, M., Sœur, J., Takeuchi, S., Germain, S., et al. (2021) · Biofabrication · doi:10.1088/1758-5090/abfca8 · Cited by 68
Kühnl, J., Tao, T. P., Brandmair, K., Gerlach, S., Rings, T., Müller‐Vieira, U., Przibilla, J., Géniès, C., Jacques, C., Schepky, A. G., et al. (2020) · Toxicology · doi:10.1016/j.tox.2020.152637 · Cited by 59
Self-citationYang, S., Chen, Z., Cheng, Y., Liu, T., Yin, L., Pu, Y., & Liang, G. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.115861 · Cited by 61
Organ-on-a-chip technology: turning its potential for clinical benefit into reality
Haddrick, M., & Simpson, P. B. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.03.011 · Cited by 63
Liver-on-a-chip devices: the pros and cons of complexity
Dalsbecker, P., Adiels, C. B., & Goksör, M. (2022) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00346.2021 · Cited by 64
Emulating human microcapillaries in a multi-organ-chip platform
Hasenberg, T., Mühleder, S., Dotzler, A., Bauer, S., Labuda, K., Holnthoner, W., Redl, H. R., Lauster, R., & Marx, U. (2015) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2015.09.038 · Cited by 59
“We recently introduced a Multi-Organ-Chip (MOC) platform to model organ-organ 104 interactions (Maschmeyer et al., 2015b; Wagner et al., 2013).”
MethodSelf-citationPlant leaves as templates for soft lithography
Wu, W., Guijt, R. M., Silina, Y. E., Koch, M., & Manz, A. (2016) · RSC Advances · doi:10.1039/c5ra25890a · Cited by 55
Microfluidic-Based Multi-Organ Platforms for Drug Discovery
Rezaei Kolahchi, A., Khadem Mohtaram, N., Pezeshgi Modarres, H., Mohammadi, M., Geraili, A., Jafari, P., Akbari, M., & Sanati-Nezhad, A. (2016) · Micromachines · doi:10.3390/mi7090162 · Cited by 53
“(a) The 3D schematic of the liver-skin co-culture microfluidic device; and (b) The metabolic activity of the co-culture of liver and skin [158].”
BackgroundDevelopment of Skin-On-A-Chip Platforms for Different Utilizations: Factors to Be Considered
Ponmozhi, J., Dhinakaran, S., Varga‐Medveczky, Z., Fónagy, K., Bors, L. A., Iván, K., & Erdő, F. (2021) · Micromachines · doi:10.3390/mi12030294 · Cited by 57
“PDMS, PDMS membrane, natural ECM lithography multiorgan chip optimization of the parameters [67]”
BackgroundEngineered Biomimetic Membranes for Organ-on-a-Chip
Rahimnejad, M., Rasouli, F., Jahangiri, S., Ahmadi, S., Rabiee, N., Farani, M. R., Akhavan, O., Asadnia, M., Fatahi, Y., Hong, S., et al. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00531 · Cited by 59
Pump-less, recirculating organ-on-a-chip (rOoC) platform
Busek, M., Aizenshtadt, A., Koch, T., Frank, A. K., Delon, L., Martinez, M. A., Golovin, A., Dumas, C., Stokowiec, J., Grünzner, S., et al. (2022) · Lab on a Chip · doi:10.1039/d2lc00919f · Cited by 58
Self-citationDevelopment of 3D skin-equivalent in a pump-less microfluidic chip
Song, H. J., Lim, H. Y., Chun, W., Choi, K. C., Lee, T.-Y., Sung, J. H., & Sung, G. Y. (2017) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2017.11.022 · Cited by 58
Multi-organ-on-a-chip for pharmacokinetics and toxicokinetic study of drugs
Sung, J. H. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1908996 · Cited by 58
Modelling the metastatic cascade by in vitro microfluidic platforms
Samatov, T. R., Shkurnikov, M. Y., Tonevitskaya, S. A., & Tonevitsky, A. (2015) · Progress in Histochemistry and Cytochemistry · doi:10.1016/j.proghi.2015.01.001 · Cited by 56
“Unlike other microfluidic platforms it combines the co-cultivated models of different organs and perfusion by the medium constantly circulating in a closed circuit (Wagner et al., 2013).”
BackgroundSelf-citationAcetaminophen absorption and metabolism in an intestine/liver microphysiological system
Marin, T. M., de Carvalho Indolfo, N., Rocco, S. A., Basei, F. L., de Carvalho, M., de Almeida Gonçalves, K., & Pagani, E. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.11.010 · Cited by 50
Side-effect test of sorafenib using 3-D skin equivalent based on microfluidic skin-on-a-chip
Jeon, H. M., Kim, K., Choi, K. C., & Sung, G. Y. (2020) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2019.09.044 · Cited by 50
In Vitro Models for Studying Chronic Drug-Induced Liver Injury
Donato, M. T., Ferrer, G. G., & Tolosa, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911428 · Cited by 54
“The co-cultures showed long-term performance in the microfluidic multi-organ-on-chip device up to 4 weeks, and showed a dose-dependent response to troglitazone, indicating their suitability for long-term evaluations [113].”
BackgroundMethodImmune-competent human skin disease models
Bergers, L. L., Reijnders, C. M. A., van den Broek, L. J., Spiekstra, S. W., de Gruijl, T. D., Weijers, E. M., & Gibbs, S. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.05.008 · Cited by 58
Mimicking the Kidney: A Key Role in Organ-on-Chip Development
Paoli, R., & Samitier, J. (2016) · Micromachines · doi:10.3390/mi7070126 · Cited by 57
“Various organ-type models have been combined, both embedding them in a single device [16,17] and by using interconnected bioreactors [18,19].”
Devarasetty, M., Forsythe, S., Shupe, T., Soker, S., Bishop, C., Atala, A., & Skardal, A. (2017) · Biosensors · doi:10.3390/bios7030024 · Cited by 49
Human Organs‐on‐Chips: A Review of the State‐of‐the‐Art, Current Prospects, and Future Challenges
Zarrintaj, P., Saeb, M. R., Stadler, F. J., Yazdi, M. K., Nasirinezhad, M., Mohebbi, S., Seidi, F., Ganjali, M. R., & Mozafari, M. (2021) · Advanced Biology · doi:10.1002/adbi.202000526 · Cited by 56
Lab-on-a-chip systems for photodynamic therapy investigations
Chudy, M., Tokarska, K., Jastrzębska, E., Bułka, M., Drozdek, S., Lamch, Ł., Wilk, K. A., & Brzózka, Z. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.10.013 · Cited by 48
Viable cell culture in PDMS-based microfluidic devices
Tanyeri, M., & Tay, S. (2018) · Methods in cell biology · doi:10.1016/bs.mcb.2018.09.007 · Cited by 62
“…of interconnected departments, each representing a different organ, linked through a microfluidic circulatory system (Baker, 2011; Esch, King, & Shuler, 2011; Luni, Serena, & Elvassore, 2014; Maschmeyer et al., 2015; Skardal, Shupe, & Atala, 2016; Wagner et al., 2013; Zhang et al., 2009).”
3D skin models along with skin-on-a-chip systems: A critical review
Sun, W., Liu, Z., Xu, J., Cheng, Y., Yin, R., Ma, L., Li, H., Qian, X. H., & Zhang, H. (2022) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.107819 · Cited by 47
Vascularized 3D Human Skin Models in the Forefront of Dermatological Research
Rimal, R., Muduli, S., Desai, P., Marquez, A. B., Möller, M., Platzman, I., Spatz, J., & Singh, S. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303351 · Cited by 46
Allometric Scaling and Cell Ratios in Multi-Organ in vitro Models of Human Metabolism
Ucciferri, N., Sbrana, T., & Ahluwalia, A. (2014) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2014.00074 · Cited by 46
“The multi-organ-on-a-chip concept has become quite popular, with several groups in the USA, Europe, and Japan attempting to design microscaled fluidic devices for drug and toxicity testing using more than one cell type (Zhang et al., 2009; Imura et al., 2012; Wagner et al., 2013).”
BackgroundMethodInfluentialMicrotissues in Cardiovascular Medicine: Regenerative Potential Based on a 3D Microenvironment
Günter, J., Wolint, P., Bopp, A., Steiger, J., Cambria, E., Hoerstrup, S. P., & Emmert, M. Y. (2016) · Stem Cells International · doi:10.1155/2016/9098523 · Cited by 46
“Such a system could also be advantageous for drug testing in a setting that mimics the whole body [174].”
Emerging In Vitro Liver Technologies for Drug Metabolism and Inter-Organ Interactions
Bale, S. S., Moore, L., Yarmush, M., & Jindal, R. (2016) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2016.0031 · Cited by 46
“Wagner et al.67 used a Multi-Organ-Chip (MOC) with two compartments to model the 3D long-term stability of liver cells (HepaRG and hepatic stellate cells) and fresh skin biopsies.”
MethodSchimek, K. M. S., Hsu, H.-H., Boehme, M., Kornet, J. J., Marx, U., Lauster, R., Pörtner, R., & Lindner, G. (2018) · Bioengineering · doi:10.3390/bioengineering5020043 · Cited by 47
“This approach is well-established for the co-culture of human liver and skin tissue [19,20,26,30].”
BackgroundSelf-citationRiley, A., Green, V., Cheah, R., McKenzie, G., Karsai, L., England, J. A., & Greenman, J. (2019) · BMC Cancer · doi:10.1186/s12885-019-5465-z · Cited by 50
“A similar pattern has been observed studies from other groups where stabilisation of LDH release was seen after four days in a four-organ-chip model [32] and after six days in a liver/ skin co-culture [33].”
ResultJeong, S., Kim, J., Jeon, H. M., Kim, K., & Sung, G. Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312788 · Cited by 46
“However, static experimental conditions differ from those in which physiochemical reactions take place in vivo as humans receive multiple stimuli both externally and internally [27].”
BackgroundA pneumatic pressure-driven multi-throughput microfluidic circulation culture system
Satoh, T., Narazaki, G., Sugita, R., Kobayashi, H., Sugiura, S., & Kanamori, T. (2016) · Lab on a Chip · doi:10.1039/c6lc00361c · Cited by 45
Pharmacokinetic and pharmacodynamic insights from microfluidic intestine-on-a-chip models
Lee, S. H., Choi, N., & Sung, J. H. (2019) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2019.1700950 · Cited by 45
“rities of animal and human phylogenetics [14].”
Micro and Nano-Scale Technologies for Cell Mechanics
Ünal, M., Alapan, Y., Jia, H. W., Varga, A. G., Angelino, K., Aslan, M., Sayın, I., Han, C., Jiang, Y., Zhang, Z., et al. (2014) · Nanobiomedicine · doi:10.5772/59379 · Cited by 54
“Recently, a multi-organ-chip with co-cultures of 3D human artificial liver and skin tissues has been designed and tested [184].”
Background
Metadata
- Authors
- Wagner, I., Materne, E.-M., Brincker, S., Süßbier, U., Frädrich, C., Busek, M., Sonntag, F., Sakharov, D. A., Trushkin, E. V., Tonevitsky, A. G., Lauster, R., & Marx, U.
- Affiliations
- Technische Universität Berlin (DE)
- Fraunhofer Institute for Material and Beam Technology (DE)
- BioClinicum (Russia) (RU)
- Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences (RU)
- Corresponding author
- Wagner, Ilka
- Venue
- Lab on a Chip
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2013
- Volume
- 13
- Issue
- 18
- Pages
- 3538
- ISSN
- 1473-0189 (ISSN-L)
- 1473-0197
- OpenAlex
- W2087315598
- Cited by
- 476
- References
- 20
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 32 · 2023: 29 · 2022: 38 · 2021: 33 · 2020: 40 · 2019: 36 · 2018: 56 · 2017: 54 · 2016: 46 · 2015: 38 · 2014: 34 · 2013: 9
- FWCI
- 23.37
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Lab on a Chip (publishedVersion)
- PubMed (publishedVersion)
- DepositOnce (submittedVersion, public-domain)
- Fraunhofer-Publica (Fraunhofer-Gesellschaft) (submittedVersion)
- Technische Universität Berlin – Universitätsbibliothek
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Keywords
- multi-organ-on-a-chip, organ-on-a-chip, skin biopsy, long-term tissue culture, drug toxicity testing, troglitazone, tissue crosstalk, transwell culture, air-liquid interface, human skin
- MeSH terms
- Troglitazone, Cell Line, Cell Survival, Chromans, Humans, Liver, RNA, Skin, Biomass, Coculture Techniques, Thiazolidinediones, Microfluidic Analytical Techniques, Tissue Culture Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.